Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 58,416 | 58,913 | 44,695 | 36,774 | 78,672 |
| Cost of Goods | 27,284 | 26,250 | 25,591 | 22,296 | 20,704 |
| Gross Profit | 31,132 | 32,663 | 19,104 | 14,478 | 57,968 |
| Operating Expenses | 27,429 | 28,778 | 29,621 | 32,902 | 27,845 |
| Operating Income | 3,987 | 4,135 | -9,926 | -18,128 | 30,827 |
| Interest Expense | 256 | 294 | 335 | 971 | 1,712 |
| Other Income | 310 | 204 | 23,490 | 719 | 1,017 |
| Pre-tax Income | 4,041 | 4,045 | 13,229 | -18,380 | 30,132 |
| Income Tax | 1,043 | 1,836 | 4,307 | -7,850 | 13,044 |
| Net Income Continuous | 2,998 | 2,209 | 8,922 | -10,530 | 17,088 |
| Minority Interests | -15 | -10 | N/A | N/A | N/A |
| Net Income | $3,013 | $2,219 | $8,969 | $-10,530 | $17,088 |
| EPS Basic Total Ops | 0.05 | 0.04 | 0.15 | -0.18 | 0.29 |
| EPS Basic Continuous Ops | 0.05 | 0.04 | 0.15 | -0.18 | 0.29 |
| EPS Diluted Total Ops | 0.05 | 0.04 | 0.15 | -0.18 | 0.28 |
| EPS Diluted Continuous Ops | 0.05 | 0.04 | 0.15 | -0.18 | 0.28 |
| EBITDA(a) | $13,029 | $14,495 | $1,606 | $-7,130 | $43,336 |